Location of Repository

The physiology of stem cells: potential for the elderly patient

By Claire E. Stewart

Abstract

Full-text of this article is available at http://www.ismni.org/jmni/pdf/16/16STEWART.pdf

Topics: Stem Cells, Myoblasts, Differentiation, Insulin-like Growth Factors
Publisher: The International Society of Musculoskeletal and Neuronal Interactions
Year: 2010
OAI identifier: oai:www.e-space.mmu.ac.uk:2173/98334

Suggested articles

Preview

Citations

  1. (1995). Actions of anabolic hormones and growth factors on cultured neonatal heart cells. Growth Regul
  2. (2002). Activation of an adipogenic program in adult myoblasts with age. Mech Ageing Dev doi
  3. (1990). Activation of insulin-like growth factor gene expression during work-induced skeletal muscle growth.
  4. (2003). Adaptations of the IGF system during malignancy: human skeletal muscle versus the systemic environment. Horm Metab Res doi
  5. (1975). An analysis of nuclear numbers in individual muscle fibers during differentiation and growth: a satellite cell-muscle fiber growth unit. J Exp Zool doi
  6. (2002). BMP4-expressing muscle-derived stem cells differentiate into osteogenic lineage and improve bone healing in immunocompetent mice. Mol Ther doi
  7. (2002). Breakout session 3: issues related to muscle growth, atrophy, and tissue engineering. Clin Orthop doi
  8. (2000). Characterisation of the IGF system in a primary adult human skeletal muscle cell model, and comparison of the effects of insulin and IGF-I on protein metabolism. doi
  9. (2003). Cytokines, insulin-like growth factor 1, sarcopenia, and mortality in very old community-dwelling men and women: the Framingham Heart Study. doi
  10. (1996). differentiation, and survival: multiple physiological functions for insulinlike growth factors. Physiol Rev
  11. (2002). Generation of different fates from multipotent muscle stem cells. Development
  12. (1994). Homeobox genes and muscle patterning. Cell doi
  13. (2003). hormones, and body composition at a crossroad. doi
  14. (2002). Identification of a novel population of muscle stem cells in mice: potential for muscle regeneration.
  15. IGF-II ameliorates the dystrophic phenotype and coordinately down-regulates programmed cell death. doi
  16. (1993). IGFI is required for normal embryonic growth in mice. Genes Dev doi
  17. (1996). Insulin-like growth factor binding protein-5 modulates muscle differentiation through an insulin-like growth factor-dependent mechanism. doi
  18. (1996). Insulin-like growth factor-II is an autocrine survival factor for differentiating myoblasts. doi
  19. (1992). Interplay between proliferation and differentiation within the myogenic lineage. Dev Biol doi
  20. (1996). IRS-1-mediated inhibition of insulin receptor tyrosine kinase activity in TNF-alphaand obesity-induced insulin resistance. Science doi
  21. (1994). Loss of the imprinted IGF2/cation-independent mannose 6-phosphate receptor results in fetal overgrowth and perinatal lethality. Genes Dev doi
  22. (1993). Mice carrying null mutations of the genes encoding insulin-like growth factor I (Igf-1) and type 1 IGF receptor (Igf1r). Cell doi
  23. (2001). Myogenic satellite cells: physiology to molecular biology.
  24. (1995). Myogenic vector expression of insulin-like growth factor I stimulates muscle cell differentiation and myofiber hypertrophy in transgenic mice. doi
  25. (2004). Recurrent gain of chromosomes 17q and 12 in cultured human embryonic stem cells. Nat Biotechnol doi
  26. (1998). Regenerating functional myocardium: improved performance after skeletal myoblast transplantation. Nat Med doi
  27. (2003). Reprogramming cells for transplantation. Heart Fail Rev doi
  28. (2003). Sarcopenia: effects on body composition and function. doi
  29. (1994). Signaling by insulin-like growth factors in paralyzed skeletal muscle: rapid induction of IGF-1 expression in muscle fibers and prevention of interstitial cell proliferation by IGF-BP5 and IGF-BP4.
  30. (2003). Skeletal muscle stem cells. Reprod Biol Endocrinol
  31. (2003). Stem cell repair of infarcted myocardium: an overview for clinicians. Circulation doi
  32. (1999). Stem cells come of age. Sci Am doi
  33. (2003). Stem cells in the treatment of muscle and connective tissue diseases. Curr Opin Pharmacol
  34. (1996). Targeted inactivation of myogenic factor genes reveals their role during mouse myogenesis: a review.
  35. (1996). The expression of TNF-alpha by human muscle. Relationship to insulin resistance. doi
  36. (2001). The proteasome in cancer biology and treatment. Radiat Res
  37. (1992). The role of cytokines in cancer cachexia. doi
  38. (1993). Through thick and thin: wasting, obesity, and TNF-alpha. Cell doi
  39. (2000). Tumor necrosis factor-alpha-induced apoptosis is associated with suppression of insulin-like growth factor binding protein-5 secretion in differentiating murine skeletal myoblasts. doi
  40. (1994). Tumor necrosis factor: a pleiotropic cytokine and therapeutic target. Annu Rev Med doi

To submit an update or takedown request for this paper, please submit an Update/Correction/Removal Request.